HUTCHMED (China) (HCM) EBIT (2018 - 2021)
Historic EBIT for HUTCHMED (China) (HCM) over the last 6 years, with Q4 2021 value amounting to -$252.5 million.
- HUTCHMED (China)'s EBIT changed N/A to -$252.5 million in Q4 2021 from the same period last year, while for Dec 2021 it was $176.2 million, marking a year-over-year change of. This contributed to the annual value of -$43.7 million for FY2024, which is 12682.25% down from last year.
- HUTCHMED (China)'s EBIT amounted to -$252.5 million in Q4 2021.
- Over the past 5 years, HUTCHMED (China)'s EBIT peaked at $220.6 million during Q1 2021, and registered a low of -$252.5 million during Q4 2021.
- In the last 4 years, HUTCHMED (China)'s EBIT had a median value of -$5.1 million in 2018 and averaged -$5.2 million.
- Its EBIT has fluctuated over the past 5 years, first tumbled by 34304.17% in 2019, then soared by 26903.74% in 2020.
- Over the past 4 years, HUTCHMED (China)'s EBIT (Quarter) stood at -$161.1 million in 2018, then surged by 76.14% to -$38.4 million in 2019, then skyrocketed by 295.36% to $75.1 million in 2020, then crashed by 436.23% to -$252.5 million in 2021.
- Its EBIT was -$252.5 million in Q4 2021, compared to $220.6 million in Q1 2021 and $75.1 million in Q2 2020.